Latest News - Dementia & Cognitive Disorders

Friday, April 13, 2018

Sleep Deprivation Increase Levels of Amyloid Beta in the Brain

Results published in the Proceedings of the National Academy of Sciences (PNAS:published online April 9, 2018) suggest that missing even 1 night of sleep can affect levels of Amyloid-ß (Aß…

Read the full story

Tuesday, April 10, 2018

Monoclonal Antibody Binding Site on Amyloid Beta Oligomers Identified and Analyzed

Judith Silverman, Ebrima Gibbs, Xubiao Peng, and others have published results in ACS Neuroscience (published online April 4, 2018) showing the generation of monoclonal antibodies to six specific epit…

Read the full story

Monday, April 02, 2018

International Society for CNS Drug Development Names Jeffrey Cummings, MD as Recipient of Leadership and Achievement Award

The International Society for CNS Drug Development (ISCDD) announced today that they have named Jeffrey Cummings, MD as the ISCDD 2018 Leadership and Achievement Award recipient. Dr. Cummings is the D…

Read the full story

Thursday, March 29, 2018

Applications Due May 25th for Up to $600,000 in Funding for Translational Research in Alzheimer's Disease

Harrington Discovery Institute (Cleveland, OH)  and the Alzheimer's Drug Discovery Foundation (ADDF) have announced a request for proposals for the 2018 ADDF-Harrington Scholar Award. Grants …

Read the full story

Wednesday, March 28, 2018

Reducing Stigma is Key for Earlier Identification of Patients with Alzheimer's Disease

A study published in Alzheimer's & Dementia identified concerns about discrimination, severity of symptoms, and loss of decision-making power that prevent people from seeking information and c…

Read the full story

Friday, March 23, 2018

Subthreshold Increases in Beta-Amyloid Correlate with Memory Decline in Healthy Adults

Susan M. Landau, Andy Horng, and William J. Jagust for the Alzheimer's Disease Neuroimaging Initiative published findings (Neurology. 2018:published online March 23, 2018) that show amyloid i…

Read the full story

Tuesday, March 20, 2018

Global Alzheimer's Platform Foundation Partners with Lyft to Provide Free Transportation to Research Sites for Clinical Trial Participants

In partnership with Lyft (San Francisco, CA), the Global Alzheimer's Platform Foundation (GAP) (Washington, DC) is beginning a pilot program to provide free transportation to and from research sit…

Read the full story

Friday, March 16, 2018

Arterial Stiffness is Associated with Amyloid-Beta Deposition and Lower Brain Volume in Alzheimer Disease-Susceptible Regions

Results from the atherosclerosis risk in communities (ARIC)-neurocognitive study published today (Neurology. 2018;published online ahead of print March 16, 2018) show an association between arterial s…

Read the full story

Tuesday, February 27, 2018

Central Hearing Loss Is Correlated with Higher Risk of Mild Cognitive Impairment

A preliminary study has been released that shows patients with central hearing loss, (ie, sensorineural hearing loss due to brain/brainstem dysfunction), are twice as likely to have mild cognitive imp…

Read the full story

Monday, February 05, 2018

Caregiving for Dementia Innovation Challenge Award Winners Announced

AARP Services Inc and United Healthcare announced 2 winners in their Caregiving for Dementia Innovation Challenge out of 254 entries from 34 countries. The goal of the challenge was to identify and cr…

Read the full story

Wednesday, January 31, 2018

Innovative Drug Combination Addresses Neuroinflammatory Response and Amyloid-Beta Accumulation Associated with Alzheimer's Disease

AZTherapies, Inc., an advanced clinical stage pharmaceutical company developing breakthrough treatments for neurologic diseases associated with neuroinflammation and neurodegeneration, announced publi…

Read the full story

Tuesday, January 30, 2018

The National Institutes of Health Launches "Accelerating Medicines Partnership Parkinson's Disease" to Advance Treatment Research

As part of their Accelerating Medicines Partnership (AMP) initiative, which aims to foster collaboration among government, biopharmaceutical, life science, and non-profit organizations to advance medi…

Read the full story

Tuesday, January 16, 2018

The Generational Technology Gap May Be Closing—Even in Patients with Dementia

Senior Helpers, a provider of in-home services for seniors who wish to remain in their homes despite age-related illnesses and mobility challenges including dementia, Alzheimer’s disease, and Pa…

Read the full story

Tuesday, October 24, 2017

FDA Fast-Tracks Alzheon’s Anti-Amyloid Alzheimer’s Agent

The FDA has granted Fast Track designation to Alzheon, Inc.’s investigational anti-amyloid drug ALZ-801 for the treatment of Alzheimer’s disease (AD). Using a precision medicine approach, …

Read the full story

Monday, October 02, 2017

US Postal Service Issues Alzheimer’s Disease Semipostal Stamps

New stamps for Alzheimer’s disease awareness are coming soon from the US Postal Service. Under its semipostal discretionary program, the Postal Service will issue five stamps over a 10-year peri…

Read the full story
Load More